- Home
- ACRV vs EVG Comparison
ACRV vs EVG Comparison
Compare ACRV & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- EVG
- Stock Information
- Founded
- ACRV 2018
- EVG 2005
- Country
- ACRV United States
- EVG United States
- Employees
- ACRV N/A
- EVG N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- EVG Investment Managers
- Sector
- ACRV Health Care
- EVG Finance
- Exchange
- ACRV Nasdaq
- EVG Nasdaq
- Market Cap
- ACRV 59.9M
- EVG 144.8M
- IPO Year
- ACRV 2022
- EVG N/A
- Fundamental
- Price
- ACRV $1.18
- EVG $10.95
- Analyst Decision
- ACRV Strong Buy
- EVG
- Analyst Count
- ACRV 5
- EVG 0
- Target Price
- ACRV $19.75
- EVG N/A
- AVG Volume (30 Days)
- ACRV 1.3M
- EVG 49.4K
- Earning Date
- ACRV 05-13-2025
- EVG 01-01-0001
- Dividend Yield
- ACRV N/A
- EVG 8.68%
- EPS Growth
- ACRV N/A
- EVG N/A
- EPS
- ACRV N/A
- EVG N/A
- Revenue
- ACRV N/A
- EVG N/A
- Revenue This Year
- ACRV N/A
- EVG N/A
- Revenue Next Year
- ACRV N/A
- EVG N/A
- P/E Ratio
- ACRV N/A
- EVG N/A
- Revenue Growth
- ACRV N/A
- EVG N/A
- 52 Week Low
- ACRV $1.30
- EVG $9.13
- 52 Week High
- ACRV $10.29
- EVG $10.86
- Technical
- Relative Strength Index (RSI)
- ACRV 29.23
- EVG 54.97
- Support Level
- ACRV $1.32
- EVG $10.80
- Resistance Level
- ACRV $1.50
- EVG $11.05
- Average True Range (ATR)
- ACRV 0.19
- EVG 0.20
- MACD
- ACRV 0.06
- EVG 0.03
- Stochastic Oscillator
- ACRV 2.08
- EVG 82.80
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest
Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.